Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Regulus Therapeutics Inc
Regulus Therapeutics Inc logo

RGLS - Regulus Therapeutics Inc Share News

$1.3 0.2  13.0%

Last Trade - 05/03/21

Sector
Healthcare
RiskRating
Speculative
Size
Micro Cap
Style
Momentum Trap
Market Cap £36.8m
Enterprise Value £33.8m
Revenue £3.63m
Position in Universe 5488th / 6651
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions RGLS Dividends
All News
All News Reuters News Company Announcements
BUZZ-Regulus: Rises on completing enrollment of first group in kidney drug study
10th Feb News
BRIEF-Regulus Announces Addition To Board Of Directors
27th Jan News
BRIEF-Regulus Therapeutics Inc Files Prospectus For Resale By Selling Stockholders Of Up To 47.4 Mln Shares
31st Dec '20 News
BRIEF-Point72 Asset Management Reports Passive Stake Of 8.5% In Regulus Therapeutics As Of Dec 4- Filing
9th Dec '20 News
BRIEF-Regulus Therapeutics Announces Private Placement Of Equity
1st Dec '20 News
BRIEF-Regulus Therapeutics Reports Q3 Net Loss $0.04 Per Share
5th Nov '20 News
BUZZ-Regulus Therapeutics rises on $5 mln milestone payment from Sanofi
2nd Nov '20 News
BRIEF-Regulus Therapeutics Announces Achievement Of Interim Enrollment Milestone Under Collaboration With Sanofi
2nd Nov '20 News
BRIEF-Regulus Says First Patient Dosed In Phase 1B Clinical Trial Of RGLS4326 For The Treatment Of Patients With Autosomal Dominant Polycystic Kidney Disease
15th Oct '20 News
BRIEF-Regulus Therapeutics Announces Receipt Of $5 Mln Milestone And Material Payments From Sanofi
13th Oct '20 News
BRIEF-Regulus Therapeutics Announces Restructuring Of Sanofi And Oxford Loan Agreements
31st Aug '20 News
BRIEF-Regulus Therapeutics Reports QTRLY Loss Per Share Of $0.23
13th Aug '20 News
BRIEF-Regulus Therapeutics Announces FDA Orphan Drug Designation Of RGLS4326
29th Jul '20 News
BUZZ-Regulus Therapeutics: Rises as kidney treatment gets 'orphan drug' status
29th Jul '20 News
BRIEF-Regulus Therapeutics Completes Dosing In Phase 1 Study Of Rgls4326 For The Treatment Of A Type Of Kidney Disease
22nd Jul '20 News
BRIEF-Regulus Therapeutics Reports Q1 Loss Per Share Of $0.25
14th May '20 News
BRIEF-Regulus Therapeutics Receives Letter From Nasdaq - SEC Filing
27th Mar '20 News
BRIEF-Regulus Therapeutics Posts Quarterly Loss Per Share Of $0.23
12th Mar '20 News
BRIEF-Regulus Reports Fourth Quarter And Year-End 2019 Financial Results And Recent Updates
12th Mar '20 News
BRIEF-Regulus Therapeutics Reinitiates Multiple Ascending Dose Study Of RGLS4326 For The Treatment Of ADPKD
13th Feb '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.